509 related articles for article (PubMed ID: 29852159)
1. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
2. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
3. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
4. Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study.
Rufin KGA; do Valle HA; McAlpine JN; Elwood C; Hanley GE
Fertil Steril; 2024 Mar; 121(3):531-539. PubMed ID: 38043843
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
McAlpine JN; Hanley GE; Woo MM; Tone AA; Rozenberg N; Swenerton KD; Gilks CB; Finlayson SJ; Huntsman DG; Miller DM;
Am J Obstet Gynecol; 2014 May; 210(5):471.e1-11. PubMed ID: 24412119
[TBL] [Abstract][Full Text] [Related]
7. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
8. No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador S; Scott S; Francis JA; Agrawal A; Giede C
J Obstet Gynaecol Can; 2017 Jun; 39(6):480-493. PubMed ID: 28527613
[TBL] [Abstract][Full Text] [Related]
9. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention.
Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI
Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884
[TBL] [Abstract][Full Text] [Related]
11. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
[TBL] [Abstract][Full Text] [Related]
12. Risks and benefits of opportunistic salpingectomy during vaginal hysterectomy: a decision analysis.
Cadish LA; Shepherd JP; Barber EL; Ridgeway B
Am J Obstet Gynecol; 2017 Nov; 217(5):603.e1-603.e6. PubMed ID: 28619689
[TBL] [Abstract][Full Text] [Related]
13. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
[TBL] [Abstract][Full Text] [Related]
14. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
[TBL] [Abstract][Full Text] [Related]
15. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation?
Danis RB; Della Badia CR; Richard SD
J Minim Invasive Gynecol; 2016; 23(6):928-32. PubMed ID: 27234430
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.
Hanley GE; Niu J; Han J; Fung S; Bryant H; Kwon JS; Huntsman DG; Finlayson SJ; McAlpine JN; Miller D; Earle CC
CMAJ Open; 2022; 10(2):E466-E475. PubMed ID: 35640988
[TBL] [Abstract][Full Text] [Related]
17. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
18. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
19. The Trend, Feasibility, and Safety of Salpingectomy as a form of Permanent Sterilization.
Kim AJ; Barberio A; Berens P; Chen HY; Gants S; Swilinski L; Acholonu U; Chang-Jackson SC
J Minim Invasive Gynecol; 2019; 26(7):1363-1368. PubMed ID: 30771489
[TBL] [Abstract][Full Text] [Related]
20. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.
van Lieshout LAM; Steenbeek MP; De Hullu JA; Vos MC; Houterman S; Wilkinson J; Piek JM
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD012858. PubMed ID: 31456223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
